M3 Biotechnology, Inc. is a start-up originating from Washington State University (WSU), developing a small molecule therapeutic with promising early efficacy and safety in treatment of neuro-degenerative diseases such as Alzheimer's and Parkinson's.
Click here to access the company's website.
M3 Biotechnology raises $15.2M, launches clinical trial for drug that could reverse Alzheimer’s
November 2, 2017
Alzheimer’s remains one of the biggest puzzles in the medical world. It’s a devastating disease that impacts millions of people across the globe, but there are no treatments that can halt or reverse it. M3 Biotechnology, a Seattle-based biotech startup, is hoping it has the answer to that puzzle... [Click for more] ...